Trials / Completed
CompletedNCT01938417
Tobramycin Exposure From Active Calcium Sulfate Bone Graft Substitute
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 12 (actual)
- Sponsor
- University of Lausanne Hospitals · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to assess the systemic absorption and disposition of tobramycin in patients treated with a tobramycin-laden bone graft substitute (Osteoset® T).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tobramycin |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2008-03-01
- First posted
- 2013-09-10
- Last updated
- 2013-09-11
Source: ClinicalTrials.gov record NCT01938417. Inclusion in this directory is not an endorsement.